“Mendelian randomisation and experimental medicine approaches to interleukin-6 as a drug target in pulmonary arterial hypertension.” Mark Toshner, Colin Church, Lars Harbaum,<i>et al</i>.<i>Eur Respir J</i>2022; 59: 2002463.

Authors:

Published: 2022-07-07

DOI: 10.1183/13993003.52463-2020

Source: Full article

---

Abstract

No abstract found.